BackSinopharm Group Ltd. Overview

Sinopharm Group Ltd. Long Term Debt

Track Sinopharm Group Ltd.'s long-term debt ($6.6B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$6.56B
↓ 11.17% YoYΔ $-824.11M vs prior year quarter

Peer trimmed avg / median

Loading

Sinopharm Group Ltd. Long Term Debt History

Loading

Sinopharm Group Ltd. vs. peers: Long Term Debt Comparison

Loading

Sinopharm Group Ltd. Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sinopharm Group Ltd. (SHTDF) FAQ

As of the most recent data (June 2026), SHTDF shows a long-term debt of $6.6B. That compares with $7.4B in the prior-year period — down 11.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SHTDF's long-term debt is now $6.6B (was $7.4B) — a 11.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Sinopharm Group Ltd. is outperforming or lagging.

Tracking SHTDF's long-term debt over time shows whether Sinopharm Group Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $6.6B That compares with $7.4B in the prior-year period — down 11.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Sinopharm Group Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $6.6B) with ownership activity and broader fundamentals.